Literature DB >> 11259361

Interethnic variability in human drug responses.

D A Evans1, H L McLeod, S Pritchard, M Tariq, A Mobarek.   

Abstract

The scientific study of interethnic differences in responses to drugs has been extant for 80 years. Many of these differences have been described at the phenotypic level, and some have been explained by genetic factors. However, it is frequently difficult to disentangle accurately the hereditary and environmental influences in phenotypic comparisons. This is where the recent developments in knowledge of the genes responsible for drug receptors are starting to make a big impact. The beta 2 adrenoceptor is described; it has three genetic polymorphisms. The different genotypes influence responses to agonists such as albuterol (Salbutamol). New gene frequency data including those for Saudi Arabians, Indians, and Africans are shown. The expanding body of knowledge about genetic (and interethnic) variability in drug receptors is likely to be important in clinical medicine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259361

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

Review 1.  The challenge of asthma in minority populations.

Authors:  Albin B Leong; Clare D Ramsey; Juan C Celedón
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

2.  Admixture-matched case-control study: a practical approach for genetic association studies in admixed populations.

Authors:  Hui-Ju Tsai; Jennifer Y Kho; Nishat Shaikh; Shweta Choudhry; Mariam Naqvi; Daniel Navarro; Henry Matallana; Richard Castro; Craig M Lilly; H George Watson; Kelley Meade; Michael Lenoir; Shannon Thyne; Elad Ziv; Esteban González Burchard
Journal:  Hum Genet       Date:  2005-11-05       Impact factor: 4.132

3.  Intra- and inter-ethnic differences in the allele frequencies of cytochrome P450 2B6 gene in Chinese.

Authors:  Su Guan; Min Huang; Xin Li; Xiao Chen; Eli Chan; Shu-Feng Zhou
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

4.  Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics.

Authors:  Hui-Ju Tsai; Nishat Shaikh; Jennifer Y Kho; Natalie Battle; Mariam Naqvi; Daniel Navarro; Henry Matallana; Craig M Lilly; Celeste S Eng; Gunjan Kumar; Shannon Thyne; H George Watson; Kelley Meade; Michael LeNoir; Shweta Choudhry; Esteban G Burchard
Journal:  Hum Genet       Date:  2006-04-05       Impact factor: 4.132

Review 5.  Pharmacogenetic tactics and strategies: implications for paediatrics.

Authors:  W W Weber
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 6.  Pharmacogenetics of Lipid-lowering Therapies.

Authors:  Jose M Ordovas; Haiqing Shen
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

7.  Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature.

Authors:  Rika Yuliwulandari; Qomariyah Sachrowardi; Nao Nishida; Miwa Takasu; Lilian Batubara; Tri Panjiasih Susmiarsih; Jecti Teguh Rochani; Riyani Wikaningrum; Risa Miyashita; Taku Miyagawa; Abdul Salam Mudzakir Sofro; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2007-12-27       Impact factor: 3.172

8.  Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations.

Authors:  Sevtap Savas; Steffen Schmidt; Hamdi Jarjanazi; Hilmi Ozcelik
Journal:  Hum Genomics       Date:  2006-03       Impact factor: 4.639

9.  Attitudes toward psychopharmacology among hospitalized patients from diverse ethno-cultural backgrounds.

Authors:  Gabriel Thorens; Marianne Gex-Fabry; Daniele F Zullino; Ariel Eytan
Journal:  BMC Psychiatry       Date:  2008-07-09       Impact factor: 3.630

10.  Differential Gene Expression across Breed and Sex in Commercial Pigs Administered Fenbendazole and Flunixin Meglumine.

Authors:  Jeremy T Howard; Audrey T O'Nan; Christian Maltecca; Ronald E Baynes; Melissa S Ashwell
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.